Nucleic acid therapies: AAV-based epigenetic perturbation - from translational disease models to anti-arrhythmic strategies
- Funding ID
81X4300131
- Project number
1803
- Institution
- Georg-August-Universität Göttingen - Universitätsmedizin
- Project leader
- Laura Zelarayan
- Site
- Göttingen
- Project type
- Innovation Cluster
- Funding
- € 122.100,00
- Begin
- 01.11.2023
- End
- 31.10.2026
- Partner projects